BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2307839)

  • 1. Effects of recombinant murine tumor necrosis factor-alpha on immune function.
    Gordon C; Wofsy D
    J Immunol; 1990 Mar; 144(5):1753-8. PubMed ID: 2307839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.
    Mise-Omata S; Sugiura T; Higashi K; Yamashita U
    Jpn J Cancer Res; 1999 Dec; 90(12):1277-84. PubMed ID: 10665643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunomodulatory potential of probiotic conditioned medium on murine macrophages.
    Al-Najjar MAA; Abdulrazzaq SB; Alzaghari LF; Mahmod AI; Omar A; Hasen E; Athamneh T; Talib WH; Chellappan DK; Barakat M
    Sci Rep; 2024 Mar; 14(1):7126. PubMed ID: 38531887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.
    Mejia-Vilet JM; Parikh SV; Song H; Fadda P; Shapiro JP; Ayoub I; Yu L; Zhang J; Uribe-Uribe N; Rovin BH
    Nephrol Dial Transplant; 2019 Jul; 34(7):1197-1206. PubMed ID: 29800348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.
    Sanders AE; Maixner W; Nackley AG; Diatchenko L; By K; Miller VE; Slade GD
    J Pain; 2012 Jan; 13(1):21-31. PubMed ID: 22036516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytokine in the lupus nephritis.
    Iwata Y; Furuichi K; Kaneko S; Wada T
    J Biomed Biotechnol; 2011; 2011():594809. PubMed ID: 22028590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine disturbances in systemic lupus erythematosus.
    Jacob N; Stohl W
    Arthritis Res Ther; 2011 Jul; 13(4):228. PubMed ID: 21745419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNF-alpha therapies in systemic lupus erythematosus.
    Zhu LJ; Yang X; Yu XQ
    J Biomed Biotechnol; 2010; 2010():465898. PubMed ID: 20625488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor necrosis factor-alpha in systemic lupus erythematosus.
    Aringer M; Smolen JS
    Arthritis Res Ther; 2008; 10(1):202. PubMed ID: 18226185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance.
    Zhao YX; Lajoie G; Zhang H; Chiu B; Payne U; Inman RD
    Infect Immun; 2000 Mar; 68(3):1243-51. PubMed ID: 10678933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor and other cytokines in murine lupus.
    Theofilopoulos AN; Lawson BR
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I49-55. PubMed ID: 10577973
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer cells and tumour necrosis factor-alpha-mediated enteropathy in mice.
    Garside P; Mowat AM
    Immunology; 1993 Feb; 78(2):335-7. PubMed ID: 8473022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.
    Ishida H; Muchamuel T; Sakaguchi S; Andrade S; Menon S; Howard M
    J Exp Med; 1994 Jan; 179(1):305-10. PubMed ID: 8270873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
    Cope AP; Londei M; Chu NR; Cohen SB; Elliott MJ; Brennan FM; Maini RN; Feldmann M
    J Clin Invest; 1994 Aug; 94(2):749-60. PubMed ID: 8040330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor.
    Taverne J; Sheikh N; de Souza JB; Playfair JH; Probert L; Kollias G
    Immunology; 1994 Jul; 82(3):397-403. PubMed ID: 7959874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.
    Horwitz DA; Jacob CO
    Springer Semin Immunopathol; 1994; 16(2-3):181-200. PubMed ID: 7716704
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced natural killer cell activity and IL-2 production in malnourished cancer patients.
    Villa ML; Ferrario E; Bergamasco E; Bozzetti F; Cozzaglio L; Clerici E
    Br J Cancer; 1991 Jun; 63(6):1010-4. PubMed ID: 2069835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does malaria select for predisposition to autoimmune disease?
    Butcher GA
    J R Soc Med; 1991 Aug; 84(8):451-3. PubMed ID: 1886110
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor necrosis factor and immunopathology.
    Piguet PF; Grau GE; Vassalli P
    Immunol Res; 1991; 10(2):122-40. PubMed ID: 1717618
    [No Abstract]   [Full Text] [Related]  

  • 20. Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.
    Piguet PF
    Springer Semin Immunopathol; 1992; 13(3-4):345-54. PubMed ID: 1411901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.